Loading…
Effects of Inositol 1,4,5-triphosphate on Osteoclast Differentiation in RANKL-induced Osteoclastogenesis
The receptor activator of NF-κB ligand (RANKL) signal is an activator of tumor necrosis factor receptor-associated factor 6 (TRAF6), which leads to the activation of NF-κB and other signal transduction pathways essential for osteoclastogenesis, such as Ca 2+ signaling. However, the intracellular lev...
Saved in:
Published in: | The Korean journal of physiology & pharmacology 2012, 16(1), , pp.31-36 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The receptor activator of NF-κB ligand (RANKL) signal is an activator of tumor necrosis factor receptor-associated factor 6 (TRAF6), which leads to the activation of NF-κB and other signal transduction pathways essential for osteoclastogenesis, such as Ca
2+
signaling. However, the intracellular levels of inositol 1,4,5-trisphosphate (IP
3
) and IP
3
-mediated cellular function of RANKL during osteoclastogenesis are not known. In the present study, we determined the levels of IP
3
and evaluated IP
3
-mediated osteoclast differentiation and osteoclast activity by RANKL treatment of mouse leukemic macrophage cells (RAW 264.7) and mouse bone marrow-derived monocyte/macrophage precursor cells (BMMs). During osteoclastogenesis, the expression levels of Ca
2+
signaling proteins such as IP
3
receptors (IP
3
Rs), plasma membrane Ca
2+
ATPase, and sarco/endoplasmic reticulum Ca
2+
ATPase type2 did not change by RANKL treatment for up to 6 days in both cell types. At 24 h after RANKL treatment, a higher steady-state level of IP
3
was observed in RAW264.7 cells transfected with green fluorescent protein (GFP)-tagged pleckstrin homology (PH) domains of phospholipase C (PLC) δ, a probe specifically detecting intracellular IP
3
levels. In BMMs, the inhibition of PLC with U73122 [a specific inhibitor of phospholipase C (PLC)] and of IP
3
Rs with 2-aminoethoxydiphenyl borate (2APB; a non-specific inhibitor of IP
3
Rs) inhibited the generation of RANKL-induced multinucleated cells and decreased the bone-resorption rate in dentin slice, respectively. These results suggest that intracellular IP
3
levels and the IP
3
-mediated signaling pathway play an important role in RANKL-induced osteoclastogenesis. |
---|---|
ISSN: | 1226-4512 2093-3827 |
DOI: | 10.4196/kjpp.2012.16.1.31 |